|
1
|
Garcia-Aguilar J, Mellgren A, Sirivongs P,
Buie D, Madoff RD and Rothenberger DA: Local excision of rectal
cancer without adjuvant therapy: A word of caution. Ann Surg.
231:345–351. 2000.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Garcia-Aguilar J, Renfro LA, Chow OS, Shi
Q, Carrero XW, Lynn PB, Thomas CR Jr, Chan E, Cataldo PA, Marcet
JE, et al: Organ preservation for clinical T2N0 distal rectal
cancer using neoadjuvant chemoradiotherapy and local excision
(ACOSOG Z6041): Results of an open-label, single-arm,
multi-institutional, phase 2 trial. Lancet Oncol. 16:1537–1546.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lee SJ and Park YS: Serial evaluation of
anorectal function following low anterior resection of the rectum.
Int J Colorectal Dis. 13:241–246. 1998.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Benson AB, Venook AP, Al-Hawary MM,
Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D,
Engstrom PF, et al: Rectal cancer, version 2.2018, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
16:874–901. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rackley TP, Ma RM, Brown CJ and Hay JH:
Transanal local excision for patients with rectal cancer: Can
radiation compensate for what is perceived as a nondefinitive
surgical approach? Dis Colon Rectum. 59:173–178. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sasaki T, Ito Y, Ohue M, Kanemitsu Y,
Kobatake T, Ito M, Moriya Y and Saito N: Postoperative
chemoradiotherapy after local resection for high-risk T1 to T2 low
rectal cancer: Results of a single-arm, multi-institutional, phase
II clinical trial. Dis Colon Rectum. 60:914–921. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Borstlap WA, Coeymans TJ, Tanis PJ,
Marijnen CA, Cunningham C, Bemelman WA and Tuynman JB:
Meta-analysis of oncological outcomes after local excision of pT1-2
rectal cancer requiring adjuvant (chemo)radiotherapy or completion
surgery. Br J Surg. 103:1105–1116. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Greenberg JA, Shibata D, Herndon JE II,
Steele GD Jr, Mayer R and Bleday R: Local excision of distal rectal
cancer: An update of cancer and leukemia group B 8984. Dis Colon
Rectum. 51:1185–1191; discussion 1191-1184. 2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kajiwara Y, Ueno H, Hashiguchi Y,
Mochizuki H and Hase K: Risk factors of nodal involvement in T2
colorectal cancer. Dis Colon Rectum. 53:1393–1399. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chang HC, Huang SC, Chen JS, Tang R,
Changchien CR, Chiang JM, Yeh CY, Hsieh PS, Tsai WS, Hung HY and
You JF: Risk factors for lymph node metastasis in pT1 and pT2
rectal cancer: A single-institute experience in 943 patients and
literature review. Ann Surg Oncol. 19:2477–2484. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kobayashi H, Mochizuki H, Kato T, Mori T,
Kameoka S, Shirouzu K, Saito Y, Watanabe M, Morita T, Hida J, et
al: Is total mesorectal excision always necessary for T1-T2 lower
rectal cancer? Ann Surg Oncol. 17:973–980. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
He J, Lou Z, Zhang W, Meng R, Fu C, Yu E
and Wang H, Hao L and Wang H: Analysis of risk factors associate
with lymph node metastasis of T1 and T2 rectal cancer. Zhonghua Wei
Chang Wai Ke Za Zhi. 18:1016–1019. 2015.(In Chinese). PubMed/NCBI View Article : Google Scholar
|
|
13
|
Masaki T, Matsuoka H, Sugiyama M, Abe N,
Sakamoto A, Watanabe T, Nagawa H and Atomi Y: Tumor budding and
evidence-based treatment of T2 rectal carcinomas. J Surg Oncol.
92:59–63. 2005.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lowry AC, Simmang CL, Boulos P, Farmer KC,
Finan PJ, Hyman N, Killingback M, Lubowski DZ, Moore R, Penfold C,
et al: Consensus statement of definitions for anorectal physiology
and rectal cancer: Report of the tripartite consensus conference on
definitions for anorectal physiology and rectal cancer, washington,
D.C., May 1, 1999. Dis Colon Rectum. 44:915–919. 2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Watanabe T, Muro K, Ajioka Y, Hashiguchi
Y, Ito Y, Saito Y, Hamaguchi T, Ishida H, Ishiguro M, Ishihara S,
et al: Japanese society for cancer of the colon and rectum (JSCCR)
guidelines 2016 for the treatment of colorectal cancer. Int J Clin
Oncol. 23:1–34. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ueno H, Jones AM, Wilkinson KH, Jass JR
and Talbot IC: Histological categorisation of fibrotic cancer
stroma in advanced rectal cancer. Gut. 53:581–586. 2004.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tong LL, Gao P, Wang ZN, Yue ZY, Song YX,
Sun Z, Lu Y, Xing CZ and Xu HM: Is pT2 subclassification feasible
to predict patient outcome in colorectal cancer? Ann Surg Oncol.
18:1389–1396. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ding PR, An X, Cao Y, Wu XJ, Li LR, Chen
G, Lu ZH, Fang YJ, Wan DS and Pan ZZ: Depth of tumor invasion
independently predicts lymph node metastasis in T2 rectal cancer. J
Gastrointest Surg. 15:130–136. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Saraste D, Gunnarsson U and Janson M:
Predicting lymph node metastases in early rectal cancer. Eur J
Cancer. 49:1104–1108. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yoshida N, Nakanishi M, Inoue K, Yasuda R,
Hirose R, Naito Y, Itoh Y, Arita T, Murayama Y, Kuriu Y, et al:
Pure well-differentiated adenocarcinoma is a safe factor for lymph
node metastasis in T1 and T2 colorectal cancer: A pilot study.
Gastroenterol Res Pract. 2018(8798405)2018.PubMed/NCBI View Article : Google Scholar
|
